People from racial and ethnic minority groups had higher risks of COVID-19 infections, but outcomes varied based on access to primary care physicians and insurance.
Members of racial and ethnic minority groups had higher risks of COVID-19 infection and disease severity, according to a recent study published in JAMA Network Open. They found that people who are African American, Asian American, and Hispanic were significantly more likely to test positive for COVID-19 than White individuals.
“Our results are consistent with previous findings that suggest that racial and ethnic minority groups face a higher risk of ICU admission and COVID-19 positivity but a lower risk of mortality than White populations. However, current meta-analyses do not provide associations with socioeconomic variables, which are highly implicated in COVID-19 outcomes,” wrote investigators, who were led by Shruti Magesh and Daniel John, both with the department of surgery at the University of California, San Diego.
In this study, investigators examined the associations of race and ethnicity with COVID-19 positivity rates, mortality, hospitalization, and ICU admissions in the United States. Then they associated these outcomes with various social determinants through adjusted and unadjusted relative risk ratio (RR) and odds ratio (OR) calculations.
Investigators searched databases for studies published between Jan. 1, 2020, and Jan. 6, 2021. They found 68 studies where they could examine the association of clinical care quality with COVID-19 positivity, mortality, ICU admission, and hospitalization. They assessed preventable hospital stays, ratio of the population to primary care physicians, and percentage of uninsured individuals, as well as disease severity through ICU admission and hospitalization rates among various racial and ethnic groups.
Although people from racial and ethnic minority groups had higher risks of COVID-19, the outcomes varied among patient populations. For example, investigators found that increased deprivation was associated with increased mortality, especially among Asian Americans, but the opposite was true for Hispanics. Investigators said this inconsistency suggests that further research is needed of COVID-19 infections among Hispanics.
Additionally, an increase in county median income was associated with increased mortality rates in Asian Americans. Investigators speculated that a large number of Asian Americans work in healthcare settings where their exposure to the COVID-19 was higher.
Investigators also found that lack of insurance among African Americans and a lack of access to primary care among Hispanics were associated with higher COVID-19 infections.
Investigators pointed out the studies they assessed had incomplete or missing data on mortality, positivity, ICU admission, and hospitalization rates. There was also limited data on racial and ethnic groups and a lack of information on comorbidities in some studies.
Latest Vaccines and Antiviral Treatments Show Promising Results in Reducing Severe COVID Outcomes
March 7th 2024It was found in a recent study that the updated Moderna, Pfizer-BioNTech and Novavax COVID-19 vaccines, when combined with antiviral treatments like nirmatrelvir and molnupiravir, can significantly decrease the chances of hospitalization and death from current COVID-19 variants.
Read More
In this episode, Peter Wehrwein, managing editor of Managed Healthcare Executive, speaks with Dr. Rodrigo Cerda. Dr. Cerda has been recently promoted to the position of senior vice president of health services and chief medical officer of Independence Blue Cross in Philadelphia. He is also a member of Managed Healthcare Executive’s editorial advisory board. Peter and Dr. Cerda discuss his new role at the Independence Blue Cross, what it means to be a chief medical officer at an insurer these days, valued-based care, social determinants of health, and, of course, the pandemic.
Listen
How More Prompt Action Could Have Saved Thousands of U.S. COVID-19 Deaths
December 10th 2023Researchers of a study compared Israel's CVOID-19 booster rollout experience to the United States to ask the question: How many lives could the U.S. have saved if boosters were authorized sooner?
Read More
Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.
Listen
A Cup or Two of Joe a Day Could Keep COVID-19 Infection Away
November 19th 2023Coffee, rich in polyphenolic compounds like chlorogenic acid (CGA), caffeic acid (CAA), cafestol, melanoidins and trigonelline, has been recognized as a dominant source of CGA in various studies. Previous studies suggest that CGA in coffee can positively impact blood pressure, lipid profile, glycemia and insulin resistance.
Read More
The Challenges, Strategies of COVID-19 Misinformation Interventions
November 16th 2023COVID-19 misinformation interventions should involve public health experts, establish consistent outcome measures and more to address health misinformation at individual, community and systems levels, according researchers of a recent study.
Read More
Latest Vaccines and Antiviral Treatments Show Promising Results in Reducing Severe COVID Outcomes
March 7th 2024It was found in a recent study that the updated Moderna, Pfizer-BioNTech and Novavax COVID-19 vaccines, when combined with antiviral treatments like nirmatrelvir and molnupiravir, can significantly decrease the chances of hospitalization and death from current COVID-19 variants.
Read More
In this episode, Peter Wehrwein, managing editor of Managed Healthcare Executive, speaks with Dr. Rodrigo Cerda. Dr. Cerda has been recently promoted to the position of senior vice president of health services and chief medical officer of Independence Blue Cross in Philadelphia. He is also a member of Managed Healthcare Executive’s editorial advisory board. Peter and Dr. Cerda discuss his new role at the Independence Blue Cross, what it means to be a chief medical officer at an insurer these days, valued-based care, social determinants of health, and, of course, the pandemic.
Listen
How More Prompt Action Could Have Saved Thousands of U.S. COVID-19 Deaths
December 10th 2023Researchers of a study compared Israel's CVOID-19 booster rollout experience to the United States to ask the question: How many lives could the U.S. have saved if boosters were authorized sooner?
Read More
Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.
Listen
A Cup or Two of Joe a Day Could Keep COVID-19 Infection Away
November 19th 2023Coffee, rich in polyphenolic compounds like chlorogenic acid (CGA), caffeic acid (CAA), cafestol, melanoidins and trigonelline, has been recognized as a dominant source of CGA in various studies. Previous studies suggest that CGA in coffee can positively impact blood pressure, lipid profile, glycemia and insulin resistance.
Read More
The Challenges, Strategies of COVID-19 Misinformation Interventions
November 16th 2023COVID-19 misinformation interventions should involve public health experts, establish consistent outcome measures and more to address health misinformation at individual, community and systems levels, according researchers of a recent study.
Read More
2 Commerce Drive
Cranbury, NJ 08512